PAX8 and renal cell carcinoma: Importantly, when probing the biomarker potential for CP in the TCGA dataset, we observed that RCC cases bearing high expression of CP display lower survival compared with the low expressers (Fig. 4d) while PAX8 mRNA expression does not seem to have prognostic value (Supplementary Fig. 4D).